Ventyx Biosciences Inc.

AI Score

0

Unlock

2.21
-0.10 (-4.33%)
At close: Jan 24, 2025, 12:33 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a
Cost of Revenue 941.00K 470.00K 30.00K n/a n/a
Gross Profit -941.00K -470.00K -30.00K n/a n/a
Operating Income -207.99M -113.14M -67.15M -7.05M -4.18M
Interest Income 15.07M 4.67M 78.00K 358.00 146.00
Pretax Income -192.96M -108.43M -83.75M -28.17M -4.33M
Net Income -192.96M -107.96M -78.37M -28.53M -4.47M
Selling & General & Admin 32.23M 25.40M 8.67M 684.00K 628.00K
Research & Development 175.77M 87.74M 58.48M 6.37M 3.55M
Other Expenses 0.00 41.00K -5.45M -1K -1K
Operating Expenses 207.99M 113.14M 67.15M 7.05M 4.18M
Interest Expense n/a n/a 99.00K 358.00K 146.00K
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 207.99M 113.14M 67.15M 7.05M 4.18M
Income Tax n/a -470.00K -5.38M 358.00K 146.00K
Shares Outstanding (Basic) 58.54M 52.47M 50.41M 50.30M 50.30M
Shares Outstanding (Diluted) 58.54M 52.47M 50.41M 50.30M 50.30M
EPS (Basic) -3.3 -2.06 -1.55 -0.57 -0.09
EPS (Diluted) -3.3 -2.06 -1.55 -0.57 -0.09
EBITDA -207.84M -107.96M -67.12M n/a -1K
Depreciation & Amortization 158.00K 470.00K 30.00K 7.05M 4.18M